1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 10 NOVEMBER 2014

Cancer Drug News 10 NOVEMBER 2014

  • November 2014
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Dendreon Unlikely To Find Buyer With Provenge's Underperformance
Industry Brief - Altor Initiates Development Of ALT-803 In r/r MM Supported By Phase II SBIR Grant
Industry Brief - AstraZeneca/Pharmacyclics/Janssen Enter Immuno-Oncology Clinical Trial Collaboration
Industry Brief - MorphoSys' MOR208 Gains FDA Fast Track Designation For DLBCL
Industry Trend Analysis - FDA ODAC Vote Against MM Drug Is A Bad Start To Novartis' New Oncology Focus
Industry Brief - Phase II Trial Of Cabozantinib/Erlotinib Shows Positive Top-Line Results
Industry Brief - BI Reports Positive Phase III Results For Afatinib In Asian NSCLC Patients With del19 Mutation
Industry Brief - Exelixis Achieves Enrolment Target In Cabozantinib Phase III MRCC Study
Industry Brief - Tivantinib Phase II Study Meets Primary Endpoint Of PFS In Metastatic PCA
Industry Brief - Myriad/AbbVie Sign Expanded Agreement For Tumor BRACAnalysis CDx
Industry Trend Analysis - Future Of Amgen's Trebananib In Question After Disappointing Overall Survival Results
Industry Brief - FDA Grants ODD To Merrimack's MM-141 For PC
Industry Brief - FDA Approves Cyramza+Paclitaxel Combination for Advanced/Metastatic GC
Industry Brief - European VHP Clearance For Celsion's ThermoDox Phase III HCC Study
Industry Brief - Provectus Submits PV-10 Phase III Melanoma Protocol To FDA
Industry Brief - Felicitex/Selvita Collaborate To Target Quiescent Cancers
Industry Trend Analysis - AstraZeneca Strengthens Immuno-Oncology Capabilities With Diagnostics Acquisition

Table Of Contents

Cancer Drug News 10 NOVEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.